Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy

Regina Promberger, Rupert Bartsch, Martina Mittlböck et al.|Clinical Breast Cancer|2015

Cited by 5